Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastatic Breast Cancer
NCT02583828Completed
- Sponsor
- Capital Medical University
- Start
- Jun 2015
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cyclophosphamide in breast cancer (4 arms), sponsored by Capital Medical University. Primary endpoint: Progression Free Survival at 2 years. Started Jun 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02583828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583828.